| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $10.1M | +7.4% | -10.1% |
| SG&A Expense | $3.8M | -11.6% | +33.8% |
| Operating Income | -$13.9M | -1.4% | +1.2% |
| Pre-tax Income | -$11.8M | +4.1% | +11.0% |
| Income Tax | -$15K | +28.6% | +51.6% |
| Net Income | -$11.8M | +4.1% | +10.9% |
| EPS (Basic) | -$0.08 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $56.9M | -51.4% | +254.3% |
| Short-term Investments | $138.1M | +59.0% | +179.2% |
| Current Assets | $198.3M | -4.3% | +194.5% |
| Total Assets | $199.4M | -4.3% | +189.3% |
| Current Liabilities | $9.0M | -2.2% | -0.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$34.5M | — | — |
| Capital Expenditures | $12K | — | — |
| Investing Cash Flow | -$63.5M | — | — |
| Financing Cash Flow | $120.7M | — | — |
| Free Cash Flow | -$34.5M | — | — |
| +11.1% |
| +38.5% |
| EPS (Diluted) | -$0.08 | +11.1% | +38.5% |
| $9.6M |
| -2.8% |
| -3.7% |
| Stockholders' Equity | $189.8M | -4.4% | +221.8% |